Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Licong Liang

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Interventional Medicine|February 5, 2024
Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablationFeilong Ye, Lulu Xie, Licong Liang, et al.
Liver Research (Beijing, China)|April 13, 2026
Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapyLicong Liang, Yuchan Liang, Wensou Huang, et al.
Journal of Hepatocellular Carcinoma|December 3, 2021
Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular CarcinomaJingjun Huang, Wensou Huang, Meixiao Zhan, et al.
Investigative Ophthalmology & Visual Science|July 24, 2023
Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic ConjunctivitisZhiyan Tao, Wei Liu, Qin Chen, et al.
Chinese Medical Journal|September 10, 2021
Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled studyJingjun Huang, Mingyue Cai, Wensou Huang, et al.
Journal of Hepatocellular Carcinoma|March 18, 2022
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective StudyJingjun Huang, Yongjian Guo, Wensou Huang, et al.
Acta Pharmaceutica Sinica. B|January 1, 2026
Injectable hydrogel-mediated co-delivery of oncolytic adenovirus and melphalan for retinoblastoma control and vision preservationGuoqing Wang, Kai Wu, Zongliang Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2024
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II studyMingyue Cai, Wensou Huang, Wei Liang, et al.
Frontiers in Immunology|March 18, 2022
Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort StudyMingyue Cai, Wensou Huang, Jingjun Huang, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 25, 2023
Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched studyYongjian Guo, Jingqiang Wu, Licong Liang, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Interventional Medicine|February 5, 2024
Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablationFeilong Ye, Lulu Xie, Licong Liang, et al.
Liver Research (Beijing, China)|April 13, 2026
Screening the advantageous population for liver cancer undergoing yttrium-90 microsphere selective internal radiation therapyLicong Liang, Yuchan Liang, Wensou Huang, et al.
Journal of Hepatocellular Carcinoma|December 3, 2021
Drug-Eluting Bead Transarterial Chemoembolization Combined with FOLFOX-Based Hepatic Arterial Infusion Chemotherapy for Large or Huge Hepatocellular CarcinomaJingjun Huang, Wensou Huang, Meixiao Zhan, et al.
Investigative Ophthalmology & Visual Science|July 24, 2023
Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic ConjunctivitisZhiyan Tao, Wei Liu, Qin Chen, et al.
Chinese Medical Journal|September 10, 2021
Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled studyJingjun Huang, Mingyue Cai, Wensou Huang, et al.
Journal of Hepatocellular Carcinoma|March 18, 2022
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective StudyJingjun Huang, Yongjian Guo, Wensou Huang, et al.
Acta Pharmaceutica Sinica. B|January 1, 2026
Injectable hydrogel-mediated co-delivery of oncolytic adenovirus and melphalan for retinoblastoma control and vision preservationGuoqing Wang, Kai Wu, Zongliang Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2024
Lenvatinib, sintilimab plus transarterial chemoembolization for advanced stage hepatocellular carcinoma: A phase II studyMingyue Cai, Wensou Huang, Wei Liang, et al.
Frontiers in Immunology|March 18, 2022
Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort StudyMingyue Cai, Wensou Huang, Jingjun Huang, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 25, 2023
Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched studyYongjian Guo, Jingqiang Wu, Licong Liang, et al.
Pageof 4